Clinical trial
Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia…
NCT00004933 · Alliance for Clinical Trials in Oncology, Other · Terminated
Key facts
| NCT number | NCT00004933 |
|---|---|
| Title | Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa |
| Official title | A Phase III Study of Interferon-Refractory Patients With BCR/ABL(+) Chronic Myelogenous Leukemia (CML) Treated With Homoharringtonine (NSC #141633) vs. Hydroxyurea |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | hydroxyurea, Homoharringtonine |
| Enrollment | 5 |
| Start date | Jan 1, 2000 |
| Primary completion | May 1, 2001 |
| Completion | May 1, 2001 |
| First posted | Apr 28, 2004 |
| Last update posted | Jul 4, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: